tiprankstipranks
Halozyme price target raised to $72 from $70 at H.C. Wainwright
PremiumThe FlyHalozyme price target raised to $72 from $70 at H.C. Wainwright
4d ago
Halozyme Therapeutics Achieves Record Revenue in 2024
Premium
Company Announcements
Halozyme Therapeutics Achieves Record Revenue in 2024
4d ago
Positive Outlook and Strategic Growth: Brendan Smith’s Buy Rating on Halozyme
Premium
Ratings
Positive Outlook and Strategic Growth: Brendan Smith’s Buy Rating on Halozyme
4d ago
Halozyme assumed with an Overweight at Morgan Stanley
PremiumThe FlyHalozyme assumed with an Overweight at Morgan Stanley
9d ago
Halozyme Board Member Connie Matsui Steps Down
Premium
Company Announcements
Halozyme Board Member Connie Matsui Steps Down
9d ago
Halozyme’s Strategic Advancements and Market Potential Justify Buy Rating
Premium
Ratings
Halozyme’s Strategic Advancements and Market Potential Justify Buy Rating
19d ago
Halozyme price target raised to $70 from $68 at H.C. Wainwright
PremiumThe FlyHalozyme price target raised to $70 from $68 at H.C. Wainwright
1M ago
Exxon and Shell cautious on Q4, Flutter cuts guidance: Morning Buzz
Premium
The Fly
Exxon and Shell cautious on Q4, Flutter cuts guidance: Morning Buzz
2M ago
Halozyme raises FY25 adjusted EPS view to $4.95-$5.35 from $4.45-$4.85
Premium
The Fly
Halozyme raises FY25 adjusted EPS view to $4.95-$5.35 from $4.45-$4.85
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100